Winton Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-16,227
Closed -$105K – 906
2023
Q4
$105K Sell
16,227
-22,610
-58% -$146K 0.01% 707
2023
Q3
$367K Buy
38,837
+21,021
+118% +$253K 0.03% 468
2023
Q2
$249K Buy
+17,816
New +$304K 0.02% 590
2021
Q4
– Sell
-20,498
Closed -$442K – 1474
2021
Q3
$442K Buy
20,498
+430
+2% +$10.4K 0.02% 920
2021
Q2
$515K Buy
20,068
+4,550
+29% +$97.2K 0.03% 904
2021
Q1
$283K Buy
+15,518
New +$258K 0.02% 1167
2020
Q1
– Sell
-47,805
Closed -$367K – 1570
2019
Q4
$367K Sell
47,805
-23,240
-33% -$136K 0.01% 1327
2019
Q3
$377K Buy
+71,045
New +$441K ﹤0.01% 1184

Other funds holding CDMO

Winton Group's CDMO Position: Q1 2024 in Review

Winton Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 16,227 shares — an estimated $105K sold.

Winton Group first reported a position in CDMO in Q3 2019 and held it in 8 quarters. The position peaked at $515K in Q2 2021. 167 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Winton Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Winton Group sold 16,227 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $105K.
  • Winton Group first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Winton Group's Avid Bioservices, Inc. Common Stock position peaked at $515K in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Winton Group's 13F filing for Q1 2024, filed 14 May 2024.